◎reply_notice
slotsninjanodepositbonus| U.S. stocks change| Lilly rose by more than 4% to record a record high of tilpositide injection approved in China
Lillyslotsninjanodepositbonus.US) rose more than 4%, hitting a high of US$816.61, a new high since its listing. On the news front, on May 21, the official website of the State Food and Drug Administration showed that Lilly Mofonda (tierpositide injection) was approved by the State Food and Drug Administration (NMPA) to improve the treatment of adult patients with type 2 diabetesslotsninjanodepositbonusBlood sugar control. Tilpositide is a GIPR and GLP-1R agonist injected once a week.
Unless otherwise specified, the copyright of this article belongs to feature buy. Please indicate the source when reprinting.
Category： Health
Read more
- Message
-